Results(4745)
An observational study evaluating long-acting injectable cabotegravir (CAB-LA; APRETUDE) healthcare provider and user experience and utilization for pre-exposure prophylaxis (PrEP) against HIV in Canada (223857)
Canada
EU PAS number:
EUPAS1000000801
First published:
11/09/2026
Study
Ongoing
Real-World Patient-Reported Outcomes After Initiation of Adjuvant Ribociclib Plus Endocrine Therapy in Early HR+/HER2− Breast Cancer: A Multicentre Prospective Observational Study in Croatia (PRO-QoL-Cro)
Croatia
EU PAS number:
EUPAS1000001116
First published:
11/09/2026
Study
Planned
Use of antipsychotics in children and adolescents in the Spanish National Health System: network project with real-world data from five Autonomous Communities to inform evidence-based health policies (Children and Adolescents Antipsychotic Research for Evidence-based Strategies – CARES Project)
Spain
EU PAS number:
EUPAS1000000591
First published:
11/09/2026
Study
Ongoing
Health Data Research Platform of the Balearic Islands (PRISIB)
Hospital inpatient records
Pharmacy dispensing records
Primary care medical records
Spain
First published:
10/09/2026
Data source
Human
Record completeness: 80%
Health Research Institute of the Balearic Islands (IdISBa)
Spain
First published:
10/09/2026
Institution
Laboratory/Research/Testing facility
Poitiers University Hospital (CHU de Poitiers)
France
First published:
10/09/2026
Institution
Hospital/Clinic/Other health care facility
Long-Term Surveillance of Ocrelizumab-Treated Patients With Multiple Sclerosis (MANUSCRIPT Study)
Australia
Denmark
France
Germany
Italy
Sweden
EU PAS number:
EUPAS28619
First published:
10/09/2026
Study
Ongoing
An Observational, Ambispective Cohort Study Evaluating the Long-term Effectiveness and Safety of Dinutuximab Beta or Conventional Treatment as Maintenance Therapy in Patients With High Risk Neuroblastoma
China
EU PAS number:
EUPAS46562
First published:
10/09/2026
Study
Ongoing
Periodic Assessment Survey of Certified Prescribers to Assess Understanding of the Risks with the BKEMV® Risk Evaluation and Mitigation Strategy (REMS)
United States
EU PAS number:
EUPAS1000000367
First published:
09/09/2026
Study
Ongoing
Frequency of HIV diagnoses among people using oral and LA PrEP (223555)
United States
EU PAS number:
EUPAS1000000371
First published:
09/09/2026
Study
Finalised
Real World Utilization and Effectiveness of Romosozumab Among Osteoporosis Patients in Hong Kong (20250006)
China
EU PAS number:
EUPAS1000000724
First published:
09/09/2026
Study
Ongoing
Evaluation of the Effectiveness of Implementation of Additional Risk Minimization Measures (aRMM) Materials for Xeljanz® (Tofacitinib) / Rheumatoid Arthritis (RA) indication in Nigeria via a Survey among Prescribers: A Non-Interventional Post Authorization Safety Study (PASS).
Nigeria
EU PAS number:
EUPAS1000000900
First published:
08/09/2026
Study
Planned
Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie (Embryotox), Charité-Universitätsmedizin, Berlin
Germany
First published:
07/09/2026
Institution
Educational Institution
ENCePP partner
Rare Eye Diseases Registry
Other
Belgium
Estonia
France
Ireland
Italy
Netherlands
First published:
07/09/2026
Data source
Human
Record completeness: 55%
Semaglutide in patients with heart failure with reduced ejection fraction: safety and effectiveness – a target trial emulation
France
Netherlands
Portugal
Sweden
EU PAS number:
EUPAS1000000809
First published:
07/09/2026
Study
Ongoing
Evaluation of the Effectiveness of the Additional Risk Minimisation Measures for Hemgenix®: PASS Survey Among Physicians in European Countries
Austria
France
Germany
Ireland
Italy
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000001088
First published:
07/09/2026
Study
Ongoing
Effectiveness and safety of cardiac glycosides in HFrEF: target trial emulation and transportability of DIG and DIGIT-HF effects to a contemporary real-world population
France
Sweden
EU PAS number:
EUPAS1000001109
First published:
07/09/2026
Study
Ongoing
Periodic Assessment Survey of Patients/Caregivers to Assess Understanding of the Risks with the BKEMV® Risk Evaluation and Mitigation Strategy (REMS)
United States
EU PAS number:
EUPAS1000000368
First published:
07/09/2026
Study
Ongoing
DARWIN EU® - Assess the role and performance of AI-based phenotyping in non-interventional studies
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000001107
First published:
07/09/2026
Study
Ongoing
Effects of maternal modafinil treatment on fetal development and neonatal growth parameters - a multicenter case series of the European Network of Teratology Information Services (ENTIS)
Australia
France
Germany
Israel
Italy
Japan
Netherlands
Spain
Switzerland
Türkiye
United Kingdom
United States
EU PAS number:
EUPAS1000001106
First published:
07/09/2026
Study
Finalised
A multicentre, non-interventional, cohort analysis describing the patients’ experience focusing on safety events among metastatic hormone-sensitive prostate cancer patients treated with Androgen Receptor Pathway Inhibitors (ARPIs) followed through a Telemonitoring tool funded by the French national healthcare insurance complemented with a chart review (ESPERANTO)
France
EU PAS number:
EUPAS1000000759
First published:
07/09/2026
Study
Ongoing
Prospective cohort study to assess the performance of tools to describe the Natural History of CytoMegaloVirus infection and transmission in FAMILIes with children attending daycare centers in France (CMV FAMILI study)
France
EU PAS number:
EUPAS1000001054
First published:
04/09/2026
Study
Planned
DARWIN EU® - Enabling pregnancy and mother-child research in DARWIN EU® Data Network - PeriNet
Croatia
Denmark
Finland
France
Germany
Hungary
Netherlands
Norway
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000812
First published:
04/09/2026
Study
Finalised
Healthcare Professional (HCP) Survey to Assess the Effectiveness of the Additional Risk Minimization Measures (aRMM) for Casgevy® (exagamglogene autotemcel)
Germany
Italy
Spain
EU PAS number:
EUPAS1000000704
First published:
03/09/2026
Study
Ongoing
Cohort Study to Evaluate Fetal and Infant Outcomes Following Maternal Exposure to Bimekizumab during Pregnancy
United States
EU PAS number:
EUPAS1000001042
First published:
03/09/2026
Study
Ongoing
European Sickle Cell Disease Cohort – Hydroxyurea – Extension study (ESCORT-HU Extension)
France
Germany
Greece
Italy
EU PAS number:
EUPAS1000000066
First published:
03/09/2026
Study
Finalised
Prognostic value of Continuous Glucose Monitoring metrics for microvascular and macrovascular complications in diabetes using Freestyle Libre® system records and SNDS French claims database linkage (FACULTY)
France
EU PAS number:
EUPAS1000000188
First published:
03/09/2026
Study
Ongoing
Monitoring of the Lenalidomide Pregnancy Prevention Programme (PPP) Implementation and Effectiveness in Europe (Lena-PIE Europe)
Germany
EU PAS number:
EUPAS49520
First published:
03/09/2026
Study
Ongoing
Monitoring of the Lenalidomide Pregnancy Prevention Programme (PPP) Implementation and Effectiveness in Germany (Lena-PIE Germany)
Germany
EU PAS number:
EUPAS45747
First published:
03/09/2026
Study
Ongoing
Observational Study on the Safety and Effectiveness of Tepezza (teprotumumab) in South Korea
Korea, Republic of
EU PAS number:
EUPAS1000001085
First published:
02/09/2026
Study
Planned
Effects of triple pharmacological therapy on post-discharge outcomes in patients with COPD
Belgium
France
Korea, Republic of
Malta
Poland
Singapore
Spain
EU PAS number:
EUPAS1000000444
First published:
02/09/2026
Study
Planned
Xarelto Paediatric VTE PASS Drug Utilization Study: An observational, longitudinal, multi-source drug utilization safety study to evaluate the drug use patterns and safety of rivaroxaban oral suspension in children under two years with venous thromboembolism (XAPAEDUS)
Denmark
France
Spain
Sweden
EU PAS number:
EUPAS46800
First published:
01/09/2026
Study
Planned
A Prospective, Observational Cohort Study to Assess Long-Term Safety in Patients Prescribed Epidyolex® with a Focus on Drug-induced Liver Injury (DILI)
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS47466
First published:
01/09/2026
Study
Ongoing
Detection of therapeutic cascades associated with gabapentinoids and benzodiazepines in adults over 65 years old in Spain using BIFAP through prescription sequence symmetry analysis (GABALOOP)
Spain
EU PAS number:
EUPAS1000000241
First published:
01/09/2026
Study
Ongoing
Implementation of controlled access to and distribution of medicinal products in European Union (CONTROL-EU)
Austria
Greece
Latvia
Netherlands
Portugal
Slovenia
Spain
Sweden
EU PAS number:
EUPAS1000000313
First published:
01/09/2026
Study
Finalised
Real World Evaluation of Sotorasib among Chinese Non-Small Cell Lung Cancer Patients (20240175)
China
EU PAS number:
EUPAS1000000636
First published:
31/08/2026
Study
Finalised
209452 - A targeted safety study, EPI-ZOSTER-030 VS US DB, to evaluate the safety of Shingrix in adults ≥ 50 years of age in the United States
United States
EU PAS number:
EUPAS37156
First published:
31/08/2026
Study
Finalised
Health Impact - Swedish Population Evidence Enabling Data-linkage
Birth registry
Cancer registry
Death registry
Disease registry
Drug registry
Hospital discharge records
Hospital inpatient records
Hospital outpatient visit records
Population registry
Primary care medical records
Vaccination registry
Sweden
First published:
28/08/2026
Data source
Human
Record completeness: 90%
Compare data sources
Compare data sources